These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36451177)

  • 1. Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment.
    Sun CY; Yang LL; Zhao P; Yan PZ; Li J; Zhao DS
    Hereditas; 2022 Dec; 159(1):44. PubMed ID: 36451177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
    Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and molecular dynamics simulation.
    Yang R; Yang H; Jiang D; Xu L; Feng L; Xing Y
    PeerJ; 2022; 10():e14171. PubMed ID: 36389420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
    Li S; Wu X; Ma Y; Zhang H; Chen W
    J Ethnopharmacol; 2023 Jul; 311():116435. PubMed ID: 37023836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Effect and Mechanism Prediction of Fuzi-Gancao Herb Couple on Non-alcoholic Fatty Liver Disease (NAFLD) based on Network Pharmacology and Molecular Docking.
    Liu K; Yang X; Zhang G; Xiang Z
    Comb Chem High Throughput Screen; 2024; 27(5):773-785. PubMed ID: 37317908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network pharmacology and molecular docking study on the effect of Kaempferol in treatment of metabolic associated fatty liver disease.
    Kaixuan Z; Dong Z; Huiwei B; Lijing LI
    J Tradit Chin Med; 2022 Oct; 42(5):788-794. PubMed ID: 36083487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network pharmacology analysis of Chaihu Lizhong Tang treating non-alcoholic fatty liver disease.
    Zhang M; Yuan Y; Zhou W; Qin Y; Xu K; Men J; Lin M
    Comput Biol Chem; 2020 Jun; 86():107248. PubMed ID: 32208163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology.
    Yu C; Han D; Yu J; Zhu R; Zhu C; Wang F; Zhang T
    Medicine (Baltimore); 2023 Oct; 102(42):e35460. PubMed ID: 37861538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of Triclosan in the Treatment of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology].
    Zuo C; Sun DL; Zhao TH; Wang JJ; Zhang ZZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Apr; 44(2):253-261. PubMed ID: 35538760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation.
    Mao D; Guo J; Yang K; Yang F; Peng J; Jia X; Luo Z; Liu L; Yang E; Tang R; Lan H; Zheng Q
    Biochem Biophys Res Commun; 2024 Nov; 734():150424. PubMed ID: 39083974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the effect and mechanism of Hippophae rhamnoides L. triterpenoid acids on improving NAFLD based on network pharmacology and experimental validation in vivo and in vitro.
    Ren L; Wang R; Wang Y; Tie F; Dong Q; Wang H; Hu N
    J Ethnopharmacol; 2024 Dec; 335():118657. PubMed ID: 39127115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation on the mechanism of Ginkgo Folium in the treatment of Non-alcoholic Fatty Liver Disease by strategy of network pharmacology and molecular docking.
    Sun Y; Wang L; Du L; Yu H; Tian Y; Jin H; Li S; Yan S; Xiao X
    Technol Health Care; 2023; 31(S1):209-221. PubMed ID: 37038793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanism of Ginkgo biloba in treating type 2 diabetes mellitus combined with non-alcoholic fatty liver disease based on network pharmacology, molecular docking, and experimental evaluations.
    Xu S; Tang L; Qian X; Wang Y; Gong J; Yang H; Su D
    J Food Biochem; 2022 Dec; 46(12):e14419. PubMed ID: 36121703
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Peng C; Li J; Ke X; Liu F; Huang KE
    Ann Med; 2023 Dec; 55(1):2200258. PubMed ID: 37096878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Ganshuang granules on non-alcoholic fatty liver and underlying mechanism: a network pharmacology and experimental verification.
    Guoguo Z; Bingjie S; Tianyan Z; Shaoxiu JI; Jingwei LI; Yanni D; Feng L; Dong W
    J Tradit Chin Med; 2024 Feb; 44(1):122-130. PubMed ID: 38213247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Aidi Injection Treating of Nonsmall Cell Lung Cancer.
    Zhang W; Peng W; Li Y; Pan T; Feng F; Xu J; Zhou X
    Evid Based Complement Alternat Med; 2022; 2022():8350218. PubMed ID: 36523419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the Therapeutic Effects of Black Ginseng on Non-Alcoholic Fatty Liver Disease by Using Network Pharmacology and Molecular Docking.
    Wei W; Liu L; Liu X; Tao Y; Zhao X; Gong J; Wang Y; Liu S
    Chem Biodivers; 2022 Oct; 19(10):e202200719. PubMed ID: 36040357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network analysis and experimental verification of Salvia miltiorrhiza Bunge-Reynoutria japonica Houtt. drug pair in the treatment of non-alcoholic fatty liver disease.
    Chen H; Yan S; Xiang Q; Liang J; Deng X; He W; Cheng Y; Yang L
    BMC Complement Med Ther; 2024 Aug; 24(1):305. PubMed ID: 39143459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoprotective mechanism of
    Jiang G; Sun C; Wang X; Mei J; Li C; Zhan H; Liao Y; Zhu Y; Mao J
    Bioengineered; 2022 Mar; 13(3):5216-5235. PubMed ID: 35170400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.